Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2022 07:30 ET | Source: Bioventus, Inc.

Bioventus Amends CartiHeal Acquisition Structure

DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered...
May 10, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
May 03, 2022 17:47 ET | Source: Bioventus, Inc.

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that its subsidiary,...
May 02, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

DURHAM, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...
April 26, 2022 09:05 ET | Source: Bioventus, Inc.

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary financial...
April 26, 2022 08:38 ET | Source: Bioventus, Inc.

Bioventus Announces $415 Million Offering of Senior Notes

DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that, subject to...
April 25, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

DURHAM, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
April 08, 2022 09:15 ET | Source: Bioventus, Inc.

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that TheraSkin...
April 05, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on April...
April 04, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Exercises Call Option to Acquire CartiHeal

DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised...